IP Library Granted Patent US 12,410,204
Granted Patent B2
US 12,410,204 · App. 17/756,011 · Granted Sep 9, 2025

Chiral synthesis of a tertiary alcohol

Inventors: Sunny Abraham (San Diego, CA); Brant Clayton Boren (San Diego, CA); Sobhana Babu Boga (San Diego, CA); Aditya Krishnan Unni (San Diego, CA); Peter Qinhua Huang (San Diego, CA); Kevin Duane Bunker (Escondido, CA); Benjamin Anthony Pratt (Encinitas, CA)
Assignee: Recurium IP Holdings, LLC
C07F9/59C07F9/572C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,410,204
App. No.
17/756,011
Granted
Sep 9, 2025
Kind
B2
Abstract

Disclosed herein are methods for preparing tertiary alcohols from an optionally substituted phenyl ketone or an optionally substituted pyridinyl ketone that includes the use of a chiral ligand and boron trifluoride diethyl etherate. Tertiary alcohols can be used to prepare synthetic versions of natural products and/or pharmaceuticals.

Claims (70)

1. A method of preparing a tertiary alcohol, or a salt thereof, comprising combining:

an optionally substituted phenyl ketone or an optionally substituted pyridinyl ketone, or a salt of any of the foregoing, wherein when the phenyl ketone or pyridinyl ketone is substituted, the phenyl ketone and pyridinyl ketone is substituted with one or more substituents selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy;

a zinc reagent selected from the group consisting of Et 2 Zn, Me 2 Zn and Ph 2 Zn;

a chiral ligand having the structure

wherein:

R 1 is —CH 3 , —CH 2 CH 3 , —CH(CH 3 ) 2 or —C(CH 3 ) 3 ;

R 2 is H; or

R 1 and R 2 are taken together along with the carbons to which each R 1 and R 2 are attached to form an unsubstituted cyclohexyl ring;

each Ar is independently an unsubstituted or a substituted phenyl or an unsubstituted or a substituted naphthyl, wherein when an Ar is a substituted phenyl or a substituted naphthyl, the phenyl or the naphthyl is substituted with one or more substituents independently selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy; and

b is 1 or 2; and

BF 3 ·OEt 2 .

2. The method of claim 1 , wherein the optionally substituted phenyl ketone has a structure selected from the group consisting of:

wherein:

m1 is 0, 1, 2, 3 or 4;

n1 is 0, 1, 2, 3, 4 or 5;

m2 is 1 or 2;

X 1a is —CH 2 —;

X 2a is —CH 2 —, —CH(CH 3 )—, —C(CH 3 ) 2 — or O;

each R 1a and each R 1b are independently selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy; and

R 2b is an unsubstituted C 1-4 alkyl.

3. The method of claim 2 , wherein the optionally substituted ketone is selected from the group consisting of:

4. The method of claim 1 , wherein the tertiary alcohol has a structure selected from the group consisting of:

wherein:

m3 is 0, 1, 2, 3 or 4;

n2 is 0, 1, 2, 3, 4 or 5;

m4 is 1 or 2;

X 3a is —CH 2 —;

X 4a is —CH 2 —, —CH(CH 3 )—, —C(CH 3 ) 2 — or O;

each R 2a and each R 3b are independently selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy;

R 4b is an unsubstituted C 1-4 alkyl; and

R 3a and R 5b are independently —CH 3 , —CH 2 CH 3 or -Ph.

5. The method of claim 1 , wherein the optionally substituted pyridinyl ketone has a structure selected from the group consisting of:

wherein:

t1, u1 and v1 are independently 0, 1, 2 or 3;

w1, x1 and y1 are independently 0, 1, 2, 3 or 4;

t2, u2 and v2 are independently 1 or 2;

X 1g , X 1h and X 1j are each —CH 2 —;

X 2g , X 2h and X 2j are independently —CH 2 —, —CH(CH 3 )—, —C(CH 3 ) 2 — or O;

R 1g , R 1h , R 1j , R 1k , R 1l and R 1m are independently selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy; and

R 2k , R 2l and R 2m are independently an unsubstituted C 1-4 alkyl.

6. The method of claim 5 , wherein the optionally substituted pyridinyl is selected from the group consisting of:

7. The method of claim 1 , wherein the tertiary alcohol has a structure selected from the group consisting of:

wherein:

t3, u3 and v3 are independently 0, 1, 2 or 3;

w2, x2 and y2 are independently 0, 1, 2, 3 or 4;

t4, u4 and v4 are independently 1 or 2;

X 3g , X 3h and X 3j are each —CH 2 —;

X 4g , X 4h and X 4j are independently —CH 2 —, —CH(CH 3 )—, —C(CH 3 ) 2 — or O;

R 2g , R 2h , R 2j , R 3k , R 3l and R 3m are independently selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy;

R 4k , R 4l and R 4m are independently an unsubstituted C 1-4 alkyl; and

R 3g , R 3h , R 3j , R 5k , R 5l and R 5m are independently —CH 3 , —CH 2 CH 3 or -Ph.

8. The method of claim 1 , wherein the tertiary alcohol is obtained in enantiomeric purity of ≥50%.

9. The method of claim 1 , wherein the tertiary alcohol is obtained in enantiomeric purity of ≥90%.

10. The method of claim 1 , wherein the tertiary alcohol is obtained in enantiomeric purity of ≥95%.

11. The method of claim 1 , wherein the chiral ligand has the structure

wherein each Ar is an unsubstituted phenyl or a substituted phenyl substituted with one or more substituents independently selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy.

12. The method of claim 1 , wherein the chiral ligand has the structure

wherein each Ar is an unsubstituted naphthyl.

13. The method of claim 1 , wherein the chiral ligand has the structure

wherein each Ar is a substituted naphthyl substituted with one or more substituents independently selected from the group consisting of halogen, an unsubstituted C 1-4 alkyl and an unsubstituted C 1-4 alkoxy.

14. The method of claim 1 , wherein b is 1.

15. The method of claim 1 , wherein the chiral ligand has a structure selected from the group consisting of

16. The method of claim 1 , wherein the tertiary alcohol is selected from the group consisting of:

17. The method of claim 1 , wherein the tertiary alcohol obtained is selected from the group consisting of:

18. The method of claim 1 , wherein the method further comprises the use of NaHSO 3 on

wherein the use of NaHSO 3 increases the enantiomeric excess (ee %) of

compared to the ee % prior to the use of NaHSO 3 .

19. The method of claim 1 , wherein the method further comprises recrystallization of

wherein the recrystallization increases the enantiomeric excess (ee %) of

compared to the ee % prior to the recrystallization.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2022
From: ABRAHAM, SUNNY; BOGA, SOBHANA BABU; UNNI, ADITYA KRISHNAN; HUANG, PETER QINHUA; BUNKER, KEVIN DUANE; PRATT, BENJAMIN ANTHONY; BOREN, BRANT CLAYTON
To: ZENO MANAGEMENT, INC.
Reel/Frame 059905/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2022
From: ZENO MANAGEMENT, INC.
To: RECURIUM IP HOLDINGS, LLC
Reel/Frame 059905/0793 →
Continuity (3)
Provisional Application 63037761 · Jun 11, 2020
Provisional Application 62935894 · Nov 15, 2019
Related Publication 20230002426A1 · Jan 5, 2023
References Cited (90)
US 6998491B2 · Ishi et al. · 2006 [cited by applicant]
US 8198445B2 · Ishihara · 2012 [cited by examiner]
US 8624024B2 · Ishihara et al. · 2014 [cited by applicant]
US 11124518B2 · Huang et al. · 2021 [cited by applicant]
US 11261192B2 · Huang et al. · 2022 [cited by applicant]
US 20100113786A1 · Ishihara et al. · 2010 [cited by applicant]
US 20200157112A1 · Huang et al. · 2020 [cited by applicant]
US 20210139482A1 · Huang et al. · 2021 [cited by applicant]
US 20210317124A1 · Huang et al. · 2021 [cited by applicant]
US 20220024939A1 · Huang et al. · 2022 [cited by applicant]
US 20230008362A1 · Samatar et al. · 2023 [cited by applicant]
US 20230054854A1 · Samatar et al. · 2023 [cited by applicant]
US 20230068370A1 · Samatar et al. · 2023 [cited by applicant]
US 20230087941A1 · Samatar et al. · 2023 [cited by applicant]
US 20230210854A1 · Samatar et al. · 2023 [cited by applicant]
US 20230234956A1 · Huang et al. · 2023 [cited by applicant]
US 20230265097A1 · Hopkins et al. · 2023 [cited by applicant]
US 20240197743A1 · Pultar et al. · 2024 [cited by applicant]
US 20240261295A1 · Donate et al. · 2024 [cited by applicant]
US 20240299395A1 · Donate et al. · 2024 [cited by applicant]
US 20240325397A1 · Samatar et al. · 2024 [cited by applicant]
US 20240325412A1 · Donate et al. · 2024 [cited by applicant]
US 20240335447A1 · Donate et al. · 2024 [cited by applicant]
US 20240391924A1 · Huang et al. · 2024 [cited by applicant]
US 20240408097A1 · Samatar et al. · 2024 [cited by applicant]
CN 101641364A · 2010 [cited by applicant]
CN 103012061A · 2013 [cited by applicant]
EP 2128167 · 2009 [cited by applicant]
WO WO2008111371A1 · 2008 [cited by applicant]
WO WO2009110609 · 2009 [cited by applicant]
WO WO2019028008 · 2019 [cited by applicant]
WO WO2019173082 · 2019 [cited by applicant]
WO WO2020210320 · 2020 [cited by applicant]
WO WO2021097139 · 2021 [cited by applicant]
WO WO2021127039 · 2021 [cited by applicant]
WO WO2021127044 · 2021 [cited by applicant]
WO WO2021127045 · 2021 [cited by applicant]
WO WO2021127047 · 2021 [cited by applicant]
WO WO2021231653 · 2021 [cited by applicant]
WO WO2021252667 · 2021 [cited by applicant]
WO WO2022011391 · 2022 [cited by applicant]
WO WO2022136916 · 2022 [cited by applicant]
WO WO2022221143 · 2022 [cited by applicant]
WO WO2022251224 · 2022 [cited by applicant]
WO WO2022271731 · 2022 [cited by applicant]
WO WO2023064282 · 2023 [cited by applicant]
WO WO2023076485 · 2023 [cited by applicant]
WO WO2023114871 · 2023 [cited by applicant]
WO WO2023114875 · 2023 [cited by applicant]
WO WO2023114877 · 2023 [cited by applicant]
WO WO2024031048 · 2024 [cited by applicant]
WO WO2024059696 · 2024 [cited by applicant]
WO WO2024059808 · 2024 [cited by applicant]
WO WO2024102649 · 2024 [cited by applicant]
WO WO2024102650 · 2024 [cited by applicant]
WO WO2024249756 · 2024 [cited by applicant]
WO WO2025076311 · 2025 [cited by applicant]
Chen, et al., “Asymmetric Reduction of Prochiral Ketones Using Chirally Modified Sodium Borohydride” [cited by applicant]
Office Action dated Feb. 22, 2024 for CN Application No. 202080086586.1, filed Nov. 12, 2020. [cited by applicant]
Bieszczad et al., “Asymmetric Grignard Synthesis of Tertiary Alcohols through Rational Ligand Design” Angew. Chem. Int. Ed. (2017) 56:4272-4276. [cited by applicant]
Friel et al., “Aluminum-Catalyzed Asymmetric Alkylations of Pyridyl-Substituted Alkynyl Ketones with Dialkylzinc Reagents” J. Am. Chem. Soc. (2008) 130:9942-9951. [cited by applicant]
Hatano et al., “Recent Progress in the Catalytic Synthesis of Tertiary Alcohols from Ketones with Organometallic Reagents” Synthesis (2008) 11:1647-1675. [cited by applicant]
Hatano et al., “Catalytic enantioselective synthesis of sterically demanding alcohols using di(2°-alkyl) zinc prepared by the refined Charette's method” Chem. Commun. (2010) 46:5443-5445. [cited by applicant]
Hatano et al., “Catalytic enantioselective alkyl and aryl addition to aldehydes and ketones with organozinc reagents derived from alkyl Grignard reagents or arylboronic acids” Catal. Sci. Technol. (2011) 1:1149-1158. [cited by applicant]
Jeon et al., “A Green Chemistry Approach to a More Efficient Asymmetric Catalyst: Solvent-Free and Highly Concentrated Alkyl Additions to Ketones” J. Am. Chem. Soc. (2005) 127:16416-16425. [cited by applicant]
Jeon et al., “Catalytic Asymmetric Addition of Alkylzinc and Functionalized Alkylzinc Reagents to Ketones” J. Org. Chem. (2005) 70:448-455. [cited by applicant]
Özdemirhan, et al., “Enzyme-catalyzed resolution of aromatic ring fused cyclic tertiary alcohols” Asymmetry (2008) 19:2717-2720. [cited by applicant]
Ramon, et al., “Chiral Tertiary Alcohols Made by Catalytic Enantioselective Addition of Unreactive Zinc Reagents to Poorly Electrophilic Ketones?” Angew. Chem. Int. Ed. (2004) 43:284-287. [cited by applicant]
Riant, et al., “Asymmetric catalysis for the construction of quaternary carbon centres: nucleophilic addition on ketones and ketimines” Org. Biomol. Chem. (2007) 5:873-888. [cited by applicant]
Stymiest, et al., “Enantiodivergent conversion of chiral secondary alcohols into tertiary alcohols” Nature Letters (2008) 456:778-782. [cited by applicant]
Walsh, Patrick J., “Titanium-Catalyzed Enantioselective Additions of Alkyl Groups to Aldehydes: Mechanistic Studies and New Concepts in Asymmetric Catalysis” Acc. Chem. Res. (2003) 36:739-749. [cited by applicant]
Yus et al., “Synthesis of new C2-symmetrical bis(hydroxycamphorsulfonamide) ligands and their application in the enantioselective addition of dialkylzinc reagents to aldehydes and ketones” Tetrahedron: Asymmetry (2003) … [cited by applicant]
Hatano et al., “Highly active chiral phosphoramide-Zn(II) complexes as conjugate acid- base catalysts for enantioselective organozinc addition to ketones” Organic letters (2007) 9(22):4535-4538. [cited by applicant]
Hatano et al. “Commercially available neat organozincs as highly reactive reagents for catalytic enantioselective addition to ketones and aldehydes under solvent free conditions” Tetrahedron (2011) 67(24):4417-4424. [cited by applicant]
International Search Report and Written Opinion mailed Jan. 22, 2021 for PCT Application No. PCT/US2020/060298 filed Nov. 12, 2020. [cited by applicant]
International Preliminary Report on Patentability issued May 17, 2022 for PCT Application No. PCT/US2020/060298, filed Nov. 12, 2020. [cited by applicant]
Office Action dated Feb. 20, 2025 for Israeli Patent Application No. 292920, filed Nov. 12, 2020. [cited by applicant]
Office Action dated Feb. 14, 2025 for Russian Patent Application No. 2022112264, filed Nov. 12, 2020. [cited by applicant]
Deryabina et al., “Practical Course in Organic Chemistry Part II. Reactions of Organic Compounds,” Samara State University (2007). [cited by applicant]
Forrat et al., “Trans-1-Sulfonylamino-2-isoborneolsulfonylaminocyclohexane derivatives: excellentchiral ligands for the catalytic enantioselective addition of organozinc reagents to ketones,” Chem. Eur. J. (2006) 12(16)… [cited by applicant]
Huang et al., “Constructing a Quantitative Correlation between N-Substituent Sizes of Chiral Ligands and Enantioselectivities in Asymmetric Addition Reactions of Diethylzinc with Benzaldehyde, Journal of Organic Chemist… [cited by applicant]
Ojida et al., “Highly Enantioselective Reformatsky Reaction of Ketones: Chelation-Assisted Enantioface Discrimination,” Org. Lett. (2002) 4(18): 3051-3054. [cited by applicant]
Xie et al., “ ChemInform Abstract: Design and Synthesis of New Chiral Pyridine-Phosphite Ligands for the Copper-Catalyzed Enantioselective Conjugate Addition of Diethylzinc to Acyclic Enones,” Asymmetry (2009) 20:1425-1… [cited by applicant]
Office Action and Search Report dated Jul. 23, 2024 for Taiwan Patent Application No. 109139816, filed Nov. 13, 2020. [cited by applicant]
Office Action dated Apr. 27, 2024 for Russian Patent Application No. 2022112264, filed Nov. 12, 2020. [cited by applicant]
Office Action dated Nov. 12, 2024 for JP Application No. 2022-528146, filed Nov. 12, 2020. [cited by applicant]
Office Action dated Sep. 23, 2024 for Russian Patent Application No. 2022112264, filed Nov. 12, 2020. [cited by applicant]
Second Office Action dated Jul. 3, 2024 for Chinese Patent Application No. 202080086586.1, filed Nov. 12, 2020. [cited by applicant]
Extended European Search Report dated Oct. 26, 2023 for EP Application No. 20887780, filed Nov. 12, 2020. [cited by applicant]
“IUPAC-IUB Commission on Biochemical Nomenclature Abbreviated Nomenclature of Synthetic Polypeptides (Polymerized Amino Acids)* Revised Recommendations (1971)” [cited by applicant]